JPS4834885A - - Google Patents

Info

Publication number
JPS4834885A
JPS4834885A JP47087839A JP8783972A JPS4834885A JP S4834885 A JPS4834885 A JP S4834885A JP 47087839 A JP47087839 A JP 47087839A JP 8783972 A JP8783972 A JP 8783972A JP S4834885 A JPS4834885 A JP S4834885A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP47087839A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4834885A publication Critical patent/JPS4834885A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20Spiro-condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
JP47087839A 1971-09-01 1972-09-01 Pending JPS4834885A (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2143745A DE2143745A1 (de) 1971-09-01 1971-09-01 3,4-dihydro-2h-isochinolin-1-thione und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
JPS4834885A true JPS4834885A (enExample) 1973-05-22

Family

ID=5818354

Family Applications (1)

Application Number Title Priority Date Filing Date
JP47087839A Pending JPS4834885A (enExample) 1971-09-01 1972-09-01

Country Status (11)

Country Link
JP (1) JPS4834885A (enExample)
AU (1) AU4610472A (enExample)
BE (1) BE788321A (enExample)
CA (1) CA972755A (enExample)
DD (1) DD102148A5 (enExample)
DE (1) DE2143745A1 (enExample)
ES (1) ES406134A1 (enExample)
FR (1) FR2151044A1 (enExample)
IL (1) IL40250A0 (enExample)
NL (1) NL7211627A (enExample)
ZA (1) ZA725997B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89997A0 (en) * 1988-04-25 1989-12-15 Lilly Co Eli Propanamine derivatives
US5177075A (en) * 1988-08-19 1993-01-05 Warner-Lambert Company Substituted dihydroisoquinolinones and related compounds as potentiators of the lethal effects of radiation and certain chemotherapeutic agents; selected compounds, analogs and process
DE68920798T2 (de) * 1988-08-19 1995-05-18 Warner Lambert Co Substituierte Dihydroisochinolinone und verwandte Verbindungen als Verstärker der letalen Effekte von Bestrahlung und bestimmten Chemotherapeutika; ausgewählte Verbindungen, Analoga und Verfahren.
US7151102B2 (en) 2000-10-30 2006-12-19 Kudos Pharmaceuticals Limited Phthalazinone derivatives
EP1397350B1 (en) 2001-05-08 2007-02-28 Kudos Pharmaceuticals Limited Isoquinolinone derivatives as parp inhibitors
AU2003229953A1 (en) 2002-04-30 2003-11-17 Kudos Pharmaceuticals Limited Phthalazinone derivatives
US7449464B2 (en) 2003-03-12 2008-11-11 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0305681D0 (en) 2003-03-12 2003-04-16 Kudos Pharm Ltd Phthalazinone derivatives
GB0419072D0 (en) 2004-08-26 2004-09-29 Kudos Pharm Ltd Phthalazinone derivatives
GB0521373D0 (en) 2005-10-20 2005-11-30 Kudos Pharm Ltd Pthalazinone derivatives
JP2010539149A (ja) 2007-09-14 2010-12-16 アストラゼネカ アクチボラグ フタラジノン誘導体
JP5593229B2 (ja) 2007-10-17 2014-09-17 クドス ファーマシューティカルズ リミテッド 4−[3−(4−シクロプロパンカルボニル−ピペラジン−1−カルボニル)−4−フルオロ−ベンジル]−2h−フタラジン−1−オン
AR070221A1 (es) 2008-01-23 2010-03-25 Astrazeneca Ab Derivados de ftalazinona inhibidores de polimerasas, composiciones farmaceuticas que los contienen y usos de los mismos para prevenir y/o tratar tumores cancerigenos,lesiones isquemicas y otras enfermedades asociadas.
ES2598178T5 (es) 2008-10-07 2023-12-26 Kudos Pharm Ltd Formulación farmacéutica 514

Also Published As

Publication number Publication date
AU4610472A (en) 1974-03-07
NL7211627A (enExample) 1973-03-05
IL40250A0 (en) 1972-10-29
DE2143745A1 (de) 1973-03-08
BE788321A (fr) 1973-03-01
FR2151044A1 (en) 1973-04-13
ES406134A1 (es) 1975-08-01
DD102148A5 (enExample) 1973-12-05
CA972755A (en) 1975-08-12
ZA725997B (en) 1973-07-25

Similar Documents

Publication Publication Date Title
JPS4834885A (enExample)
AU2658571A (enExample)
FR2147164B1 (enExample)
AU2691671A (enExample)
AU3005371A (enExample)
AU2684071A (enExample)
AU2726271A (enExample)
AU2742671A (enExample)
AU2894671A (enExample)
AU2941471A (enExample)
AU2952271A (enExample)
AU2836771A (enExample)
AU2724971A (enExample)
AU2577671A (enExample)
AR202997Q (enExample)
AU3038671A (enExample)
AU3025871A (enExample)
AU2654071A (enExample)
AU2963771A (enExample)
AU2669471A (enExample)
AU2684171A (enExample)
AU2706571A (enExample)
AU2837671A (enExample)
AU2740271A (enExample)
AU2940971A (enExample)